Esma Yolcu
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$450KFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $450K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 20, 2018 | NIH | SBIR Phase I Exploiting activation-induced cell death as a means of inducing tolerance to kidney allografts | $225K | FasCure Therapeutics LLC |
| Jul 1, 2017 | NIH | STTR Phase I SA FasL engineered human islets as a novel product for the treatment of type diabetes | $225K | FasCure Therapeutics LLC with UNIVERSITY OF LOUISVILLE |
Peer ranks
Federal funding#2,540
Awards as PI#1,252
Patents#273
Companies
- FasCure Therapeutics LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.